Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) [Phase 2]
A Phase 2 trial of temozolomide in pre-selected advanced aerodigestive tract cancers was terminated; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-28Clinical Trial Update: Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients [Phase 2]
Phase 2 trial in elderly patients with non-small cell lung cancer compares weekly docetaxel alone to weekly docetaxel with gemcitabine. The …
-
CLINICAL_TRIALS trial_result · 2010-06-28Clinical Trial Update: Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 randomized trial comparing oral topotecan to docetaxel for second-line non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-16Clinical Trial Update: Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating intermittent docetaxel in combination with erlotinib (Tarceva) for metastatic non-small cell lung cancer has been…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating two regimens of a rebeccamycin analogue in patients with advanced or recurrent non-small cell lung cancer has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update on chemotherapy for patients with advanced non-small cell lung cancer. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
This is a completed clinical trial evaluating non-small cell lung cancer using predefined drug-targeting tumor markers.
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation [Phase 2]
A Phase 2 trial evaluated gefitinib as first-line therapy for patients with EGFR-mutant non-small cell lung cancer (adenocarcinoma); the stu…
-
CLINICAL_TRIALS trial_result · 2010-05-26Clinical Trial Update: Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC) [Phase 3]
This Phase 3 clinical trial update concerns asymptomatic brain metastasis in non-small cell lung cancer, with the study status currently unk…
-
CLINICAL_TRIALS trial_result · 2010-05-21Clinical Trial Update: A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa [Phase 4]
A completed Phase 4 study in an expanded access program evaluating long-term survival in non-small cell lung cancer patients treated with Ir…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia [Phase 3]
A Phase 3 trial in Asia compared first-line gefitinib (IRESSA) with carboplatin/paclitaxel in non-small cell lung cancer, with results poste…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC) [Phase 3]
A Phase 3 trial comparing adjuvant Vinorelbine plus Cisplatin (NP) versus NP plus Endostar in patients with completely resected stage IB-III…
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Pfizer conducted a Phase 2 trial of SU011248 in locally advanced or metastatic non-small cell lung cancer; results from the completed study …
-
CLINICAL_TRIALS trial_result · 2010-04-22Clinical Trial Update: Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
This completed clinical trial from Stanford explored serum markers associated with tumor hypoxia in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2010-04-20Clinical Trial Update: Molecular Profiling in Lung Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating molecular profiling in non-small cell lung cancer patients has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-04-12Clinical Trial Update: Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer [Phase 2]
A Phase II trial in patients with recurrent non-small cell lung cancer has completed, according to a clinical trial update.
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update evaluating the combination of carboplatin and cetuximab for Stage IIIB/IV non-small cell lung cancer. The study status …
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer [Phase 1, Phase 2]
The Phase 1/2 trial of cetuximab in combination with carboplatin and paclitaxel for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-08Clinical Trial Update: BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC) [Phase 2]
Phase II trial of BAY 43-9006 (sorafenib) in non-small cell lung cancer has completed. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-04-06Clinical Trial Update: A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) [Phase 2]
Phase 2 study of bevacizumab plus carboplatin and paclitaxel in advanced, previously untreated squamous non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 clinical trial results for chemotherapy in non-small cell lung cancer were posted.
-
CLINICAL_TRIALS trial_result · 2010-03-29Clinical Trial Update: Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the combination of pemetrexed disodium and erlotinib for advanced non-small cell lung cancer; the study …
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer [Phase 1]
Open-label Phase 1 study of a peptide vaccine in patients with stage IIb/IIIa non-small cell lung cancer; the trial sponsored by Epimmune is…
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pazopanib as pre-surgical therapy in treatment-naive non-small cell lung cancer patients; results were posted after…